ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,603Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1749

$1.46M Total Retail Price of All Prescriptions

Rank: 18 out of 1749

398 Patients Receiving at Least One Drug in Part D
31%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 398 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

10% of this provider’s 398 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

6% of this provider’s 2,794 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$170 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
QUETIAPINE FUMARATE 331 116 1 4
BENZTROPINE MESYLATE 264 94 R 2 3
LATUDA 235 57 3 35
INVEGA 229 71 4 45
DIVALPROEX SODIUM 219 102 5 15
SERTRALINE HCL 211 73 6 7
LEVOTHYROXINE SODIUM 202 72 7 37
ZIPRASIDONE HCL 200 51 8 28
RISPERIDONE 200 77 8 1
CLOZAPINE 186 88 10 11
ZOLPIDEM TARTRATE 184 41 11 9
OLANZAPINE 177 101 12 6
OXCARBAZEPINE 175 50 13 39
FLUVOXAMINE MALEATE 171 58 14 54
BUPROPION XL 160 34 15 18
ABILIFY 156 45 16 5
PRISTIQ ER 148 30 17 49
LITHIUM CARBONATE 142 26 18 20
HALOPERIDOL 140 54 19 21
OLANZAPINE ODT 134 20 20 40
TRAZODONE HCL 126 27 21 2
GEODON 124 35 22 55
SEROQUEL 122 31 23 24
TOPIRAMATE 121 36 24 29
DIVALPROEX SODIUM ER 116 15 25 13
FAZACLO 104 0 26 34
MIRTAZAPINE 101 50 27 16
CYMBALTA 97 16 28 12
HALOPERIDOL LACTATE 91 14 29 103
FANAPT 88 47 30 62
HYDROCODONE-ACETAMINOPHEN 87 43 S3 31 59
FLUOXETINE HCL 86 0 32 8
VENLAFAXINE HCL ER 86 34 32 17
OMEPRAZOLE 80 34 34 60
BUSPIRONE HCL 80 0 34 26
GABAPENTIN 79 0 36 27
PROPRANOLOL HCL 73 37 37 41
RISPERDAL CONSTA 72 27 38 42
CARBAMAZEPINE 72 15 38 46
SIMVASTATIN 71 35 40 52
LAMOTRIGINE 69 29 41 14
INVEGA SUSTENNA 67 28 42 32
CITALOPRAM HBR 67 22 42 10
ESCITALOPRAM OXALATE 62 24 44 23
HALOPERIDOL DECANOATE 60 35 45 50
TRIHEXYPHENIDYL HCL 59 25 R 46 33
VALPROIC ACID 59 12 46 58
PAROXETINE HCL 59 0 46 19
CLONIDINE HCL 52 0 49 75
AMITRIPTYLINE HCL 50 0 R 50 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.